Pyxis Oncology (PYXS) Operating Leases (2020 - 2026)
Pyxis Oncology (PYXS) posted quarterly Operating Leases of $17.0 million for Q4 2025, down 9.07% year-over-year from $18.6 million in Q4 2024, and down 2.54% quarter-over-quarter from $17.4 million in Q3 2025.
Pyxis Oncology (PYXS) Operating Leases (2020 - 2026) Analysis & Trends
Pyxis Oncology (PYXS) has reported Operating Leases for 5 consecutive years, with $17.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases fell 9.07% year-over-year to $17.0 million; the TTM figure through Dec 2025 stood at $17.0 million (down 9.07% YoY), while the FY2025 annual figure was $17.0 million, down 9.07% from the prior year.
- Operating Leases retreated to $17.0 million in Q4 2025 per PYXS's latest filing, from $17.4 million in the prior quarter.
- Across five years, Operating Leases topped out at $20.7 million in Q2 2023 and bottomed at $15.7 million in Q2 2022.
- Historically, Operating Leases has averaged $18.5 million across 4 years, with a median of $18.9 million in 2022.
- Annual changes were most pronounced in 2023 — Operating Leases soared 32.2% — and 2025, when it retreated 9.07%.
- Pyxis Oncology's Operating Leases stood at $18.9 million in 2022, then rose by 6.23% to $20.1 million in 2023, then dropped by 7.21% to $18.6 million in 2024, then declined by 9.07% to $17.0 million in 2025.
- Business Quant data shows PYXS's Operating Leases at $17.0 million in Q4 2025, $17.4 million in Q3 2025, and $17.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Pyxis Oncology | 199.01 Mn | 166.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.01 Mn |
| Dec 31, 2025 | 16.96 Mn |
| Sep 30, 2025 | 17.40 Mn |
| Jun 30, 2025 | 17.83 Mn |
| Mar 31, 2025 | 18.25 Mn |
| Dec 31, 2024 | 18.65 Mn |
| Sep 30, 2024 | 19.03 Mn |
| Jun 30, 2024 | 19.40 Mn |
| Mar 31, 2024 | 19.76 Mn |
| Dec 31, 2023 | 20.10 Mn |
| Sep 30, 2023 | 20.41 Mn |
| Jun 30, 2023 | 20.73 Mn |
| Mar 31, 2023 | 19.04 Mn |
| Dec 31, 2022 | 18.92 Mn |
| Sep 30, 2022 | 16.05 Mn |
| Jun 30, 2022 | 15.68 Mn |
| Dec 31, 2020 | 165,000.00 |